Andrew Z. Wang, MD, CEO, Capio Biosciences will present "Capiocyte: A Highly Sensitive Circulating Tumor Cell Capture Assay for Improving Cancer Management"
Capio Biosciences to present at the Liquid Biopsy Summit in San Francisco June 17-19th 2019
Kommentare